SciELO - Scientific Electronic Library Online

vol.14 issue1-2FVII polymorphisms IVS7, FVII R353Q in FVII gene and FXIII Val34Leu and its association with the risk of acute myocardial infartion in Costa Rica Patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Revista Costarricense de Cardiología

Print version ISSN 1409-4142


CHAVES BRENES, Lilliana. Antiplatelets. Rev. costarric. cardiol [online]. 2012, vol.14, n.1-2, pp.21-25. ISSN 1409-4142.

The advent of antiplatelet agents was a major advance in the treatment of thrombotic events, so that are revolutionizing the treatment of heart attack and stroke. The combination of antithrombotic antiplatelet gave better effect and improvement results and reverse of events. However, increases the side effects such as bleeding. Approximately exists around twenty antiplatelet drugs, some are administered orally or intravenously as Tirofiban, Abciximab and Eptifibatide. In this review we will talk only therapy of oral antiplatelet main, side effects, indications and precautions. Although often administrated the correct dose antiplatelet drugs, those can not always obtain the blood vessel recanalization due to resistance: syndrome antiplatelets.

Keywords : Antiplatelet agents; Aspirin; Clopidogrel; Trifluzal; Cilostal; Tricagrelor; Prasugrel; thrombosis; bleeding.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License